What does Precipio, Inc. do?
Precipio, Inc., a healthcare biotechnology company, provides cancer diagnostic products, reagents, and services in the United States. It provides diagnostic blood cancer testing services. The company offers HemeScreen, a suite of robust genetic diagnostic panels; and IV-Cell, a proprietary cell culture media that…
What is Precipio, Inc.'s P/E and P/B ratio?
Precipio, Inc. has a P/E ratio of -32.2 and a P/B ratio of 2.50.
What is Precipio, Inc.'s debt-to-equity ratio?
Precipio, Inc. has a debt-to-equity ratio of 0.24.
How much does Precipio, Inc. owe compared with what it owns?
Precipio, Inc. owes $0.31 for every $1 it owns (balance sheet Jun 2026), which is low.
What is Precipio, Inc.'s Positivity rank?
Precipio, Inc. is ranked #4,101 of 6,774 companies globally and #1,966 of 4,000 in United States on PositoAI, with a Positivity Score of 19,916.
Does Precipio, Inc. have any regulatory orders, red flags (PosiRed) or yellow flags (PosiYellow)?
No active red flags (PosiRed) or yellow flags (PosiYellow) are currently on record for Precipio, Inc..
Where can I read the latest news about Precipio, Inc.?
Recent headlines about Precipio, Inc. from the last 30 days, with links to the original articles, are on its News page on PositoAI.
Does Precipio, Inc. have a PositoAI PosiShot or QR code?
Yes. A dated PosiShot of Precipio, Inc.'s current position, a PosiQR code for its live profile and a ready-made dated mention are available on its For this company page on PositoAI.